GT200900282A - [4 (6-FLUORO-7-METHYLAMINE-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLINE-3-ILO) -PHENYLL] -5-CHLORINE-THIOPHEN-2-ILO SULFONYLIDE SALTS, AND FORMS AND METHODS RELATED TO THE SAME. - Google Patents
[4 (6-FLUORO-7-METHYLAMINE-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLINE-3-ILO) -PHENYLL] -5-CHLORINE-THIOPHEN-2-ILO SULFONYLIDE SALTS, AND FORMS AND METHODS RELATED TO THE SAME.Info
- Publication number
- GT200900282A GT200900282A GT200900282A GT200900282A GT200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A GT 200900282 A GT200900282 A GT 200900282A
- Authority
- GT
- Guatemala
- Prior art keywords
- ilo
- sulfonylide
- phenyll
- thiophen
- quinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE SULFONILUREA QUE SE HAN AISLADO COMO SOLIDOS CRISTALINOS DE ALTA PUREZA LOS CUALES SON DE UTILIDAD EN CUADROS DE TROMBOSIS LAS CUALES SON LA PRINCIPAL CAUSA DE MUERTE EN EL MUNDO INDUSTRIALIZADO.THE PRESENT INVENTION REFERS TO SULFONILUREA COMPOUNDS THAT HAVE BEEN ISOLATED AS HIGH PURITY CRYSTAL SOLIDS WHICH ARE USEFUL IN THROMBOSIS TABLES WHICH ARE THE MAIN CAUSE OF DEATH IN THE INDUSTRIALIZED WORLD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92732807P | 2007-05-02 | 2007-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200900282A true GT200900282A (en) | 2010-05-21 |
Family
ID=39651344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200900282A GT200900282A (en) | 2007-05-02 | 2009-10-30 | [4 (6-FLUORO-7-METHYLAMINE-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLINE-3-ILO) -PHENYLL] -5-CHLORINE-THIOPHEN-2-ILO SULFONYLIDE SALTS, AND FORMS AND METHODS RELATED TO THE SAME. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090042916A1 (en) |
EP (1) | EP2076510A2 (en) |
JP (1) | JP2010526105A (en) |
KR (1) | KR20100020455A (en) |
CN (1) | CN101720324A (en) |
AU (1) | AU2008247457A1 (en) |
BR (1) | BRPI0810800A2 (en) |
CA (1) | CA2686221A1 (en) |
CO (1) | CO6241155A2 (en) |
EA (1) | EA200901474A1 (en) |
EC (1) | ECSP099779A (en) |
GT (1) | GT200900282A (en) |
IL (1) | IL201829A0 (en) |
MA (1) | MA31397B1 (en) |
MX (1) | MX2009011836A (en) |
TN (1) | TN2009000452A1 (en) |
WO (1) | WO2008137809A2 (en) |
ZA (1) | ZA200907493B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2627719C (en) * | 2005-11-03 | 2016-07-12 | Portola Pharmaceuticals, Inc. | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
US20090156620A1 (en) * | 2007-05-02 | 2009-06-18 | Portola Pharmaceuticals, Inc. | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
WO2011006169A1 (en) | 2009-07-10 | 2011-01-13 | Portola Pharmaceuticals, Inc. | Methods for diagnosis and treatment of thrombotic disorders mediated by cyp2c19*2 |
US20130165459A1 (en) * | 2010-01-12 | 2013-06-27 | Norvartis Pharma Ag | Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |
WO2011137459A1 (en) | 2010-04-30 | 2011-11-03 | Portola Pharmaceuticals, Inc. | Dosage forms of elinogrel and methods of injectable administration thereof |
JP2013544271A (en) * | 2010-12-03 | 2013-12-12 | ポートラ ファーマシューティカルズ, インコーポレイテッド | Pharmaceutical compositions, dosage forms and novel forms of compounds of formula (I) and methods of use thereof |
CN106777526B (en) * | 2016-11-25 | 2020-05-01 | 江苏大学 | Genetic algorithm-based high-temperature high-pressure centrifugal impeller multidisciplinary optimization method |
WO2019126557A1 (en) | 2017-12-22 | 2019-06-27 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
US10933096B2 (en) | 2017-12-22 | 2021-03-02 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3847925A (en) * | 1971-07-15 | 1974-11-12 | En Nom Collectif Science Et Ci | Benzenesulfonyl semicarbazides |
DE3134780A1 (en) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "SULFONYL UREAS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE" |
US4720450A (en) * | 1985-06-03 | 1988-01-19 | Polaroid Corporation | Thermal imaging method |
US5314902A (en) * | 1993-01-27 | 1994-05-24 | Monsanto Company | Urea derivatives useful as platelet aggregation inhibitors |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
JP4574100B2 (en) * | 2000-02-04 | 2010-11-04 | ポートラ ファーマシューティカルズ, インコーポレイテッド | Platelet ADP receptor inhibitor |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
AU2002217999A1 (en) * | 2000-11-01 | 2002-05-15 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
AU2003210477A1 (en) * | 2002-01-09 | 2003-07-30 | Enzrel, Inc. | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
US20040242658A1 (en) * | 2003-01-08 | 2004-12-02 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
AU2004278030C1 (en) * | 2003-10-03 | 2010-12-02 | Portola Pharmaceuticals, Inc. | 2,4-Dioxo-3-quinazolinylaryl sulfonylureas |
CA2627719C (en) * | 2005-11-03 | 2016-07-12 | Portola Pharmaceuticals, Inc. | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
AU2008247483A1 (en) * | 2007-05-02 | 2008-11-13 | Portola Pharmaceuticals, Inc. | Intravenous and oral dosing of a direct-acting and reversible P2Y12 inhibitor |
US20090156620A1 (en) * | 2007-05-02 | 2009-06-18 | Portola Pharmaceuticals, Inc. | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
-
2008
- 2008-05-02 AU AU2008247457A patent/AU2008247457A1/en not_active Abandoned
- 2008-05-02 KR KR1020097025052A patent/KR20100020455A/en not_active Application Discontinuation
- 2008-05-02 JP JP2010506707A patent/JP2010526105A/en not_active Withdrawn
- 2008-05-02 MX MX2009011836A patent/MX2009011836A/en not_active Application Discontinuation
- 2008-05-02 US US12/114,742 patent/US20090042916A1/en not_active Abandoned
- 2008-05-02 BR BRPI0810800-5A2A patent/BRPI0810800A2/en not_active IP Right Cessation
- 2008-05-02 CN CN200880022604A patent/CN101720324A/en active Pending
- 2008-05-02 EP EP08747609A patent/EP2076510A2/en not_active Withdrawn
- 2008-05-02 EA EA200901474A patent/EA200901474A1/en unknown
- 2008-05-02 CA CA002686221A patent/CA2686221A1/en not_active Abandoned
- 2008-05-02 WO PCT/US2008/062584 patent/WO2008137809A2/en active Application Filing
-
2009
- 2009-10-26 ZA ZA200907493A patent/ZA200907493B/en unknown
- 2009-10-29 IL IL201829A patent/IL201829A0/en unknown
- 2009-10-30 GT GT200900282A patent/GT200900282A/en unknown
- 2009-10-30 TN TNP2009000452A patent/TN2009000452A1/en unknown
- 2009-11-20 CO CO09132279A patent/CO6241155A2/en not_active Application Discontinuation
- 2009-11-26 MA MA32376A patent/MA31397B1/en unknown
- 2009-12-02 EC EC2009009779A patent/ECSP099779A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA31397B1 (en) | 2010-05-03 |
TN2009000452A1 (en) | 2011-03-31 |
BRPI0810800A2 (en) | 2014-10-29 |
EP2076510A2 (en) | 2009-07-08 |
CA2686221A1 (en) | 2008-11-13 |
CN101720324A (en) | 2010-06-02 |
US20090042916A1 (en) | 2009-02-12 |
MX2009011836A (en) | 2010-05-20 |
CO6241155A2 (en) | 2011-01-20 |
WO2008137809A2 (en) | 2008-11-13 |
EA200901474A1 (en) | 2010-04-30 |
ECSP099779A (en) | 2010-01-29 |
KR20100020455A (en) | 2010-02-22 |
ZA200907493B (en) | 2010-07-28 |
WO2008137809A3 (en) | 2009-01-22 |
JP2010526105A (en) | 2010-07-29 |
AU2008247457A1 (en) | 2008-11-13 |
IL201829A0 (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200900282A (en) | [4 (6-FLUORO-7-METHYLAMINE-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLINE-3-ILO) -PHENYLL] -5-CHLORINE-THIOPHEN-2-ILO SULFONYLIDE SALTS, AND FORMS AND METHODS RELATED TO THE SAME. | |
UY29549A1 (en) | NEW DERIVATIVES OF FLUORENE, COMPOSITIONS THAT CONTAIN THEM AND ITS USE | |
CR11130A (en) | BENZOILAMINO-INDAN-2-SUBSTITUTED CARBOXILIC ACIDS AND RELATED COMPOUNDS | |
CR10662A (en) | METHYLPIRIDOPIRIMIDINONE COMPOUNDS | |
DOP2011000174A (en) | ORGANIC COMPOUNDS | |
UY31260A1 (en) | PIRAZOL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND APPLICATIONS. | |
CR9260A (en) | BIS ARILO AND HETEROARILO SUBSTITUTED COMPOUNDS AS SELECTIVE ANTAGONISTS OF 5HT2a | |
CR20120031A (en) | 5-FLUOROPIRIMIDINONE DERIVATIVES | |
SV2008002542A (en) | SOLID CRYSTALLINE FORMS OF TIGECICLINE AND METHODS TO PREPARE THE SAME REF. 01142.0379-00267 (AM101946SV) | |
UY33469A (en) | COMPOSITIONS AND METHODS TO MODULATE THE WNT SIGNALING ROAD | |
ECSP056063A (en) | 6-RENT OR ALQUENIL-4-AMYNOPICOLINATES AND USE OF THE SAME AS HERBICIDES | |
NO20080129L (en) | Process for the preparation of dihydroquinazolines | |
CO6741214A2 (en) | Pesticide compositions and related processes | |
EA201070966A1 (en) | FOLATES, COMPOSITIONS AND APPLICATIONS OF THE INDICATED COMPOSITIONS | |
CR20150254A (en) | CHEMICAL COMPOUNDS | |
CR20140218A (en) | COMPOUNDS OF REPLACED 1,2,5-OXADIAZOL AND ITS USE AS HERBICIDES III | |
ECSP10010058A (en) | DERIVATIVES OF QUINAZOLINADIONA, ITS PREPARATION AND ITS THERAPEUTIC APPLICATIONS | |
UY30856A1 (en) | NEW DERIVATIVES OF 2,4 DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND MAINLY AS IKK INHIBITORS | |
CO2017003004A2 (en) | New triazolo [4,5-d] pyrimidines | |
ECSP12011652A (en) | DERIVATIVES OF 5-FLUORO-2-OXOPIRIMIDINONA-1 (2H) -CARBOXAMIDA SUBSTITUIDA-N1 | |
CR11273A (en) | DERIVADOS-2-ONA DISSTITUTED IN 3, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
UY33794A (en) | DIMERIC INHIBITORS OF THE IAP | |
UY33236A (en) | DIMERIC INHIBITORS OF THE IAP | |
CR9966A (en) | ACID 1- (1- (2-ETOXIETIL-3-ETIL-7- (4-METHYLPIRIDIN-2-ILAMINO) -1H-PIRAZOLO [4,3-D] PYRIMIDIN-5-IL) PIPERIDINE-4-CARBOXYL AND SALTS OF THE SAME. | |
GT200600048A (en) | PIRROLES REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCESS. |